2015
DOI: 10.1097/mca.0000000000000303
|View full text |Cite
|
Sign up to set email alerts
|

CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 15 publications
1
6
0
Order By: Relevance
“…Therefore, the in vitro study and our present study share a concept that the deterioration of human aortic calcification by blocking angiotensin II pathway both in clinical and in vitro point of view. In terms of vascular calcification and ACEI and/or ARB, Darabian S et al reported that patients who received ACEI and/or ARB had a greater average of coronary artery calcification score [ 17 ], which is consistent with our results.…”
Section: Discussionsupporting
confidence: 92%
“…Therefore, the in vitro study and our present study share a concept that the deterioration of human aortic calcification by blocking angiotensin II pathway both in clinical and in vitro point of view. In terms of vascular calcification and ACEI and/or ARB, Darabian S et al reported that patients who received ACEI and/or ARB had a greater average of coronary artery calcification score [ 17 ], which is consistent with our results.…”
Section: Discussionsupporting
confidence: 92%
“…18 It provides more robust risk prediction than carotid IMT, C-reactive protein, ankle-brachial index, and family history of premature heart disease 19 Incorporating CAC into the Multi-Ethnic Study of Atherosclerosis (MESA) clearly improves risk stratification and discrimination over scores based on chronologic age. 20 CAC has been shown to better identify those asymptomatic individuals who would benefit from statins, 21 aspirin, 22 ACE inhibitors 23 or the polypill 24 than risk calculators or other biomarkers. Recently, a study demonstrated that a CAC score of 0 confers a low risk of mortality over a period of 15 years in individuals estimated to be at low to intermediate FRS risk and over a 5-year low risk period in individuals at high FRS risk, unaffected by age or sex.…”
Section: Evidence Supporting Cac For Risk Assessmentmentioning
confidence: 99%
“…Accumulating evidence has shown that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) exert numerous beneficial actions on cardiac and vascular structure and function beyond their blood pressure-lowering effects ( 44 , 45 ). In principle, the use of ACEIs and ARBs that produce endothelial protective effects could alleviate COVID-19 symptoms and potentially reduce the severity of the disease ( 46 ).…”
Section: Direct Influences Of Sars-cov-2 On Atherosclerosismentioning
confidence: 99%